Header

UZH-Logo

Maintenance Infos

Publications for Angus, P

Navigate back| Up a level
Export as
Group by:
Jump to:
Number of items: 3.

2016

Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; McHutchison, John G; Dufour, Jean-François; Van Vlierberghe, Hans; van Hoek, Bart; Forns, Xavier; SOLAR-2 investigators (2016). Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet Infectious Diseases, 16(6):685-697.

2015

Zeuzem, Stefan; Soriano, Vicente; Asselah, Tarik; Gane, Edward J; Bronowicki, Jean-Pierre; Angus, Peter; Lohse, Ansgar W; Stickel, Felix; Müllhaupt, Beat; Roberts, Stuart; Schuchmann, Marcus; Manns, Michael; Bourlière, Marc; Buti, Maria; Stern, Jerry O; Gallivan, John-Paul; Voss, Florian; Sabo, John P; Böcher, Wulf; Mensa, Federico J (2015). Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis. Antimicrobial Agents and Chemotherapy, 59(2):1282-1291.

2013

Zeuzem, Stefan; Asselah, Tarik; Angus, Peter; Zarski, Jean-Pierre; Larrey, Dominique; Müllhaupt, Beat; Gane, Ed; Schuchmann, Marcus; Lohse, Ansgar W; Pol, Stanislas; Bronowicki, Jean-Pierre; Roberts, Stuart; Arasteh, Keikawus; Zoulim, Fabien; Heim, Markus; Stern, Jerry O; Nehmiz, Gerhard; Kukolj, George; Böcher, Wulf O; Mensa, Federico J (2013). Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results. Antiviral Therapy, 18(8):1015-1019.

This list was generated on Thu Oct 19 08:11:46 2017 CEST.